MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about LGND

Recent news which mentions LGND

< Previous 1 2 Next >
Ligand Pharmaceuticals's Earnings: A Preview
Tickers LGND
Tags Earnings LGND Market News
From Benzinga
Merck Highlights Data On New Vaccine, Compares 'Tolerability And Safety' To Pfizer's
Tickers LGND MRK PFE
Tags PFE News Health Care
From Benzinga
Ligand Pharma Updates Annual Guidance As It Spins Out Pelican Subsidiary
Tickers LGND
Tags Health Care News Briefs
From Benzinga
Where Ligand Pharmaceuticals Stands With Analysts
Tickers LGND
Tags Benzinga Market News LGND
From Benzinga
Analyst Expectations for Ligand Pharmaceuticals's Future
Tickers LGND
Tags BZI/AAR Market News Benzinga
From Benzinga
Why Are Novan Shares Nosediving Today?
Tickers LGND NOVN
Tags LGND why it's moving Biotech
From Benzinga
3 Stocks That Smart Investors Should Be Flocking to Now
Tickers LGND NSP WGO
Tags Stocks to Buy NSP WGO
From InvestorPlace
Viking Therapeutics Outperforms Expectations: Analyst Increases Price Target Following Successful VK2809 Trial
Tickers LGND MDGL VKTX
Tags Biotech Movers General
From Benzinga
Recap: Ligand Pharmaceuticals Q1 Earnings
Tickers LGND
Tags BZI/Recaps Market News Benzinga
From Benzinga
Earnings Scheduled For February 22, 2023
Tickers KSI LBTYA LCID LGND
Tags UCTT MGRC TNL
From Benzinga
Ligand Pharmaceuticals Earnings Preview
Tickers LGND
Tags BZI/EP LGND Earnings
From Benzinga
Travere Therapeutics Scores Accelerated FDA Approval For Rare Kidney Disease Treatment
Tickers CSLLY LGND TVTX
Tags Biotech CSLLY General
From Benzinga
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
Tickers APLS BIIB CYTK EBS
Tags APLS Small Cap REGN
From Benzinga
Roth Capital Maintains Buy Rating for Ligand Pharmaceuticals: Here's What You Need To Know
Tickers LGND
Tags Benzinga Market News Analyst Ratings
From Benzinga
Tesla To $175? Here Are 10 Other Price Target Changes For Friday
Tickers AVO CLF CYTK KMX
Tags PRQR Markets AVO
From Benzinga
Some 'Transgenic Animal Platforms Are More Than Equal,' Analyst Initiating Coverage On OmniAb Says
Tickers LGND OABI
Tags Health Care News Briefs
From Benzinga
Ligand Pharma Issues Mixed Guidance For FY23
Tickers LGND
Tags Small Cap Market News Benzinga
From Benzinga
Best stock picks for 2023: Here are Wall Street analysts’ most heavily favored choices
Tickers AAPL ACIW ALK AMGN
Tags CYTK PCRX BLFS
From MarketWatch
These small-cap stocks might make you the most money in 2023, based on two important data points
Tickers ADTN ALRM APPS BOOT
Tags CIVI IJR VSTO
From MarketWatch
Earnings Outlook For Ligand Pharmaceuticals
Tickers LGND
Tags Earnings LGND Benzinga
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Tickers ACOR ARCT CLSD CTSO
Tags SONN ACOR NUTX
From Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
Tickers APLS ARDX AZN FOLD
Tags SPPI Small Cap Penny Stocks
From Benzinga
Janssen Scores Conditional Approval For Multiple Myeloma Treatment In Pretreated Patients
Tickers AHPA JNJ LGND
Tags Biotech Large Cap General
From Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
Tickers AIMD ANVS APLS BMRN
Tags SEEL Health Care BMRN
From Benzinga
Ligand Pharmaceuticals: Q2 Earnings Insights
Tickers LGND
Tags BZI/Recaps Benzinga Market News
From Benzinga
Barclays Maintains Overweight Rating for Ligand Pharmaceuticals: Here's What You Need To Know
Tickers LGND
Tags LGND Analyst Ratings Benzinga
From Benzinga
ASCO 2022: Surprising News in Cancer Research
Tickers ACLX ADPT BMY GILD
Tags LGND Recent Press Releases RHHBY
From Motley Fool
10 Biggest Price Target Changes For Monday
Tickers CODX CVNA CYTK FIGS
Tags Analyst Ratings LGND KSS
From Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
Tickers AHPA APLS ASND ATHA
Tags TMDI Offerings Biotech
From Benzinga
Ligand To Spin-Off OmniAb Via Avista Capital-Backed SPAC Merger
Tickers AHPA LGND
Tags AHPA LGND Biotech
From Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story